CSF3 and diffuse large B-cell lymphoma: Significant risk factors for sMNs in patients with DLBCL included older age, history of chronic autoimmune disease, and chemotherapy and G-CSF usage, whereas infections were associated with lowered sMN risk (Supplementary Table S5).